Drug therapy for persons with developmental disabilities: Legislation and litigation

Nirbhay N. Singh, Thomas F. Guernsey, Cynthia R. Ellis

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Given the current Zeitgeist that psychologists be granted medication prescription privileges, it is important that as clinicians they be aware of the legislation and litigation that currently provide guidelines for the use of psychotropic drugs. Recent legislation and litigation arising from the use of psychotropic drugs with persons who are developmentally disabled are used as the basis for discussion, although the implications cover all clinical populations typically served by psychologists for whom medication may be a viable treatment option. At present, institutions, physicians, and drug companies can be held legally and financially liable for injuries resulting from the use and misuse of psychotropic medication. The same conditions will apply to psychologists if or when they begin prescribing medication.

Original languageEnglish (US)
Pages (from-to)665-679
Number of pages15
JournalClinical Psychology Review
Volume12
Issue number7
DOIs
StatePublished - 1992

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Drug therapy for persons with developmental disabilities: Legislation and litigation'. Together they form a unique fingerprint.

  • Cite this